Delivery Order SPE2DB25D9357-SPE2DB25FUAGE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $55,671 to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 dose vials, a yellow fever vaccine product. This firm fixed-price delivery order, issued on June 7, 2025, with a completion date of June 30, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its Park Ridge location. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials on August 20, 2025. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 11, 2025, with performance taking place in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, will supply the yellow fever vaccine vials to support federal healthcare needs....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, a yellow fever vaccine product. The contract, issued on September 10, 2025, is a firm fixed-price delivery order with an ultimate completion date of October 1, 2025, with no set-aside designation applied. Performance will occur at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials on August 28, 2025. This firm fixed-price delivery order, which is expected to be completed by September 19, 2025, represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract carries no set-aside designation, allowing the woman-owned small business to compete directly in the federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc. on August 19, 2025, for the provision of YF-VAX 1 dose vials, a yellow fever vaccine product. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, was issued without a set-aside designation. Performance will take place at DMS Pharmaceutical Group's facility in Park Ridge, Illinois. The contract represents a discrete fulfillment under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of October 1, 2025. This firm fixed-price delivery order was issued on September 10, 2025, without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. The company brings extensive...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,189.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,560,800 doses of the YF-VAX yellow fever vaccine to support the recurring medical supply needs of military health facilities. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract (IDC) with the DLA,...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order employs firm fixed-price terms and represents a standard procurement action within the agency's pharmaceutical supply operations....
- The Defense Logistics Agency awarded a $1,113.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 Dose Vials. The contract, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. on June 26, 2025, for the supply of YF-VAX 1 dose vials. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Illinois location with an ultimate completion date of July 18, 2025. This award utilizes a firm fixed-price contract type with no set-aside designation, allowing the vendor to compete...
- SPE2DB25D9357Indefinite Delivery Contract
- SPE2DB25D9357-SPE2DB25FUAGEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, a yellow fever vaccine product. The contract, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, operates under a firm fixed-price structure with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Illinois location. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026. The IDC, awarded under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively while providing critical medical products including vaccines, prescription medications, biologics, and medical consumables to military health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/12/25 |